Laura Moran has over 18 years of experience in clinical research. She was trained in biology, epidemiology, and biostatistics at the Whitehead Institute for Biomedical Research/Massachusetts Institute of Technology and Johns Hopkins Bloomberg School of Public Health. She currently works with the ACTG (Advancing Clinical Therapeutics Globally) on the development and implementation of clinical research trials aimed at the prevention and treatment of HIV/AIDS, tuberculosis, and other infectious diseases. She is a Project Specialist for the REPRIEVE study.